Follow us for updates
© 2022 reportr.world
Read the Story →

To Ensure Vaccine Safety, Duterte Says He'll Take It First

The President also accepted Russia's vaccine offer.
by Joel Guinto
Aug 10, 2020
Photo/s: FACEBOOK/PRESIDENTIAL COMMUNICATIONS (GOVERNMENT OF THE PHILIPPINES)
Shares

President Rodrigo Duterte said Monday he would get himself vaccinated for COVID-19 once it becomes available to ensure its safety for the public. He said he was also accepting Russia's offer to supply vaccines to the Philippines.

The Department of Health on Monday said it set aside P2.4 billion to secure vaccines once they are available. The government earlier said it planned to vaccinate for free up to 20 million people.

"Ako, pagdating ng bakuna, in public magpapa-injection ako. Ako maunang mapag-eksperimentuhan (When a vaccine arrives, I will have myself injected in public. I will be the first to be experimented on)," Duterte said in a midnight address to the nation.

"Kung pwede sa akin, pwede sa lahat. Ngayon, kung hindi pwede sa akin, yan problema (If it can be administered on me, it can be given to everybody. If it can't be, that's a problem)," he said.

Duterte said he was "very happy" with Russia's vaccine offer. "Ang Russia, kaibigan natin ito. Kaya ngayon, tinatanggap namin, kung ano supply, mag-usap pa kami kung ilan supply (Russia is our friend. That's why we are accepting the offer to supply)."

Continue reading below ↓

Up to five vaccine candidates are on Phase 3 human trials, the last step before commercial availability, Dominguez said on July 31. These include three from China and one each from the U.S. and the U.K., he said. 

Continue reading below ↓
Recommended Videos

The Philippines, through the Land Bank of the Philippines and Development Bank of the Philippines, would buy enough vaccines for an initial 20 million people. At two doses each and at $10 per dose, the vaccination program could cost $400 million or P20 billion, Dominguez said.

On top the search for a vaccine, the Philippines will also hold clinical trials on Japanese-made anti-flu drug Avigan as possible treatment for COVID-19 patients.

More from reportrworld

Latest Headlines
Read Next
Recent News
The news. So what? Subscribe to the newsletter that explains what the news means for you.
The email address you entered is invalid.
Thank you for signing up to On Three, reportr's weekly newsletter delivered to your mailbox three times a week. Only the latest, most useful and most insightful reads.
By signing up to reportr.world newsletter, you agree to our Terms of Service and Privacy Policy.